Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP3 | O14638 | 1/20 | 0.33 |
| ▸ | G6PD | P11413 | 2/20 | 0.32 |
| ▸ | RORC | P51449 | 5/20 | 0.32 |
| ▸ | USP14 | P54578 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | PRF1 | P14222 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17877691 | 1.00 | ENPP3 (0.33) | ENPP3G6PDRORCUSP14KDM4E | |
| SCHEMBL17877642 | 0.96 | KDM4E (0.34) | ENPP3G6PDRORCUSP14KDM4E | |
| SCHEMBL17877657 | 0.96 | KDM4E (0.34) | ENPP3G6PDRORCUSP14KDM4E | |
| SCHEMBL17877695 | 0.96 | KDM4E (0.34) | ENPP3G6PDRORCUSP14KDM4E | |
| SCHEMBL17877655 | 0.96 | KDM4E (0.34) | ENPP3G6PDRORCUSP14KDM4E | |
| SCHEMBL17877656 | 0.91 | USP14 (0.36) | G6PDUSP14SLC6A4SLC6A3 | |
| SCHEMBL17877808 | 0.90 | PRF1 (0.33) | G6PDPTGER4PRF1 | |
| SCHEMBL17877734 | 0.87 | G6PD (0.31) | G6PDKDM4EATML3MBTL1PTGER4 | |
| SCHEMBL17877819 | 0.86 | ENPP3 (0.33) | ENPP3G6PDRORCUSP14KDM4E | |
| SCHEMBL17877821 | 0.86 | ENPP3 (0.33) | ENPP3G6PDRORCUSP14KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2020-03-03 | — | — | US | disclosed |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10581000-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CRY2, CCNE2 | ENPP3 2678/4885G6PD 2202/4885RORC 1669/4885 |
| US-20160190482-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | ENPP3 2678/4885G6PD 2202/4885RORC 1669/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.